[August 31, 2012 BY EDGAR Mr.Martin James Seniorsistant Chief Accountant Division ofrporation Finance 100 F Street, NE Re: Mindray Medical International Limited (Mindray) Form 20-F for the Fiscal Year Ended December31, 2011 Filed April30, 2012 File No.001-33036 Dear Mr.James: Sincerely, Kurt Berney of OMelveny& Myers cc: Mr. Xu Hang]
[Mindray Announces Second Quarter 2012 Financial Results Shenzhen, China August 6, 2012 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the second quarter ended June 30, 2012. Highlights for Second Quarter 2012 Net revenues were $267.8 million, an increase of 23.3%]
[Mindray Announces Second Quarter 2012 Financial Results Shenzhen, China August 6, 2012 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the second quarter ended June 30, 2012. Highlights for Second Quarter 2012 Net revenues were $267.8 million, an increase of 23.3%]
[Mindray Announces Second Quarter 2012 Financial Results STYLE="font-family:Times New Roman" SIZE="2"> Shenzhen, China August6, 2012 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the second quarter ended June30, 2012. Highlights for Second Quarter 2012 Net revenues were $267.8 million,]
[Mindray Announces Second Quarter 2012 Financial Results STYLE="font-family:Times New Roman" SIZE="2"> Shenzhen, China August6, 2012 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the second quarter ended June30, 2012. Highlights for Second Quarter 2012 Net revenues were $267.8 million,]
